Legal status by country
Is Taspoglutide legal?
Written by Aaron CuhaReviewed Sep 2026
How Taspoglutide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | Development halted during phase 3 in 2010; never submitted. | Development halted in 2010. | Development halted in 2010. | Development halted in 2010. |
US FDA status: Never approved. Phase 3 programme halted in 2010; ClinicalTrials.gov NCT01051011 records termination for high discontinuation rates mainly due to GI tolerability and a risk mitigation plan for hypersensitivity reactions. No marketing application located.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.